aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
6.11
-0.10 (-1.69%)
At close: Nov 13, 2026, 4:00 PM EST
6.34
+0.24 (3.87%)
After-hours: Nov 13, 2026, 7:38 PM EST
aTyr Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 50.25 | 10.74 | 11.06 | 22.54 | 9.98 | 2.34 |
Short-Term Investments | - | 67.94 | 61.07 | 75.62 | 56.17 | 105.58 |
Cash & Short-Term Investments | 50.25 | 78.69 | 72.13 | 98.17 | 66.15 | 107.91 |
Cash Growth | -44.29% | 9.10% | -26.53% | 48.41% | -38.70% | 240.53% |
Other Receivables | 0.58 | 0.87 | 1.74 | 2.44 | 11.78 | 0.44 |
Receivables | 0.58 | 0.87 | 1.74 | 2.44 | 11.78 | 0.44 |
Prepaid Expenses | 1.06 | 0.68 | 8.09 | 2.39 | 2.95 | 5.22 |
Total Current Assets | 51.9 | 80.24 | 81.95 | 102.99 | 80.87 | 113.57 |
Property, Plant & Equipment | 7.91 | 10.38 | 11.86 | 14.05 | 11.56 | 1.81 |
Other Long-Term Assets | - | 2.38 | 3.02 | 3.62 | 3.36 | 0.16 |
Total Assets | 59.81 | 93 | 96.83 | 120.65 | 95.79 | 115.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 15.1 | 3.89 | 4.32 | 3.53 | 3.11 | 1.03 |
Accrued Expenses | - | 9.79 | 9.39 | 11.56 | 9.86 | 4 |
Current Portion of Leases | 1.37 | 1.47 | 1.25 | 1.33 | 0.89 | 0.98 |
Total Current Liabilities | 16.46 | 15.15 | 14.97 | 16.42 | 13.86 | 6.01 |
Long-Term Leases | 9.55 | 10.57 | 12.03 | 13.77 | 10.64 | 0.4 |
Total Liabilities | 26.01 | 25.72 | 27 | 30.18 | 24.5 | 6.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 33.79 | 0.1 | 0.08 | 0.06 | 0.03 | 0.03 |
Additional Paid-In Capital | - | 673.55 | 602.02 | 558.69 | 489.5 | 481.83 |
Retained Earnings | - | -606.16 | -532.05 | -468.02 | -417.63 | -372.3 |
Comprehensive Income & Other | - | -0.01 | -0.04 | -0.07 | -0.43 | -0.26 |
Total Common Equity | 33.79 | 67.48 | 70.02 | 90.66 | 71.46 | 109.3 |
Minority Interest | - | -0.19 | -0.19 | -0.19 | -0.18 | -0.18 |
Shareholders' Equity | 33.79 | 67.29 | 69.83 | 90.47 | 71.28 | 109.13 |
Total Liabilities & Equity | 59.81 | 93 | 96.83 | 120.65 | 95.79 | 115.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 10.92 | 12.03 | 13.28 | 15.1 | 11.53 | 1.38 |
Net Cash (Debt) | 39.33 | 66.65 | 58.84 | 83.07 | 54.61 | 106.53 |
Net Cash Growth | -49.47% | 13.28% | -29.17% | 52.11% | -48.74% | 261.74% |
Net Cash Per Share | 16.04 | 28.67 | 31.69 | 61.99 | 76.87 | 223.33 |
Filing Date Shares Outstanding | 2.46 | 2.45 | 2.22 | 1.69 | 1.33 | 0.69 |
Total Common Shares Outstanding | 2.46 | 2.45 | 2.1 | 1.58 | 0.74 | 0.69 |
Working Capital | 35.43 | 65.09 | 66.99 | 86.58 | 67.01 | 107.56 |
Book Value Per Share | 13.76 | 27.53 | 33.33 | 57.30 | 96.91 | 157.31 |
Tangible Book Value | 33.79 | 67.48 | 70.02 | 90.66 | 71.46 | 109.3 |
Tangible Book Value Per Share | 13.76 | 27.53 | 33.33 | 57.30 | 96.91 | 157.31 |
Machinery | - | 3.44 | 3.74 | 4.5 | 5 | 5 |
Leasehold Improvements | - | 5.65 | 5.65 | 5.65 | 4.41 | 1.7 |